Clinical evaluation of L-asparaginase. Introduction.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D046508:Culture Techniques; D004926:Escherichia coli / Q000201:enzymology; D006168:Guinea Pigs; D006801:Humans; D007275:Injections, Intravenous; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents; D001215:Asparaginase